Nester, C. (Contributor), Appel, G. B. (Contributor), Bomback, A. S. (Contributor), Bouman, K. P. (Contributor), Cook, H. T. (Contributor), Daina, E. (Contributor), Dixon, B. P. (Contributor), Rice, K. (Contributor), Najafian, N. (Contributor), Hui, J. (Contributor), Langman, C. B. (Contributor), Lightstone, L. (Contributor), Parikh, S. V. (Contributor), Pickering, M. C. (Contributor), Sperati, C. J. (Contributor), Trachtman, H. (Contributor), Tumlin, J. (Contributor), Wetzels, J. F. M. (Contributor), Remuzzi, G. (Contributor) (
2022). Supplementary Material for: Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies. Karger Publishers.
10.6084/m9.figshare.21617358.v1